Overview
Location
Switzerland, Schaffhausen, Thayngen
Employees
5001-10000
Founded date
1983
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 29, 2026 | News from our Partners: Octapharma selects York County for its first US manufacturing site | COLUMBIA, S.C. — The South Carolina Department of Commerce (S.C. Commerce) today announced the completion of final approvals for Octapharma’s first U.S. manufacturing and production facility in York County. The $1.5 billion investment is pr... |
| Feb 26, 2026 | Abram Scientific Fuels CoagCare with $11.75 Million Series A for Rapid Diagnostics | Abram Scientific secured $11.75 million in Series A funding. This investment propels CoagCare, their portable coagulation diagnostics platform. CoagCare rapidly identifies blood clotting and bleeding disorders. It aims to revolutionize pati... |
| Feb 25, 2026 | Abram Scientific: $11.75 Million Series A Raised For Portable Coagulation Diagnostics Platform CoagCare | Abram Scientific announced it has secured $11.75 million in Series A financing to accelerate development of its proprietary portable coagulation diagnostics platform, CoagCare. The round was led by global pharmaceutical company Octapharma A... |
| Aug 20, 2024 | Octapharma USA Receives FDA Emergency Use Authorization for octaplasLG Powder, Allows U.S. Military Medical Providers Emergent Use in Treatment of Hemorrhage or Coagulopathy | PARAMUS, N.J., Aug. 20, 2024 /PRNewswire/ -- Octapharma USA has received U.S. Food and Drug Administration Emergency Use Authorization (EUA) for its proprietary octaplasLG Powder (blood group types A and AB). The EUA allows U.S. Department ... |
| Aug 13, 2024 | Octapharma USA: JAMA Network Open Publishes Study Results Demonstrating Efficacy & Safety of Balfaxar® For Warfarin Reversal in Urgent Surgery & Invasive Procedures | PARAMUS, N.J., Aug. 13, 2024 /PRNewswire/ -- Octapharma USA announced the results from the Phase III (LEX-209) study on the efficacy and safety of Balfaxar® (prothrombin complex concentrate, human-lans; marketed in Europe and Canada as octa... |
| Aug 3, 2024 | Hair Restoration and Medical Innovations: A New Era in Patient Care | In the bustling streets of Istanbul, a revolution is brewing. EsteNove, a leading hair transplant clinic, is making waves by offering exclusive packages for U.S. travelers during National Hair Loss Awareness Month. This initiative is more t... |
| Aug 1, 2024 | FDA Approves Additional Indication for Fibryga® for Fibrinogen Supplementation in Bleeding Patients with Acquired Fibrinogen Deficiency, Potentially Ushering in a New Standard of Care | PARAMUS, N.J, Aug. 1, 2024 /PRNewswire/ -- Octapharma USA, Inc. has announced the expanded approval of fibryga®, Fibrinogen (Human) Lyophilized Powder for Reconstitution, for fibrinogen replacement in bleeding patients with acquired fibrino... |
Reviews 0
FAQ about octapharmausa.com
When was octapharmausa.com founded?
octapharmausa.com was founded in 1983.
What has the press written about octapharmausa.com?
Parsers VC has collected 8 articles mentioning octapharmausa.com, among them “News from our Partners: Octapharma selects York County for its first US manufacturing site” (Jul 29, 2026) and “Abram Scientific Fuels CoagCare with $11.75 Million Series A for Rapid Diagnostics” (Feb 26, 2026).
Is octapharmausa.com still active?
Yes, octapharmausa.com is active; its latest activity on Parsers VC dates from Jul 30, 2026.